[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_13463 

# __Vaccine development and distribution technologies__

## Risks linked to this technology

* [Lack of adoption of new therapeutics and vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11412.md)
* [Lack of immunity and effective vaccine for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13992.md)
* [Little prospect of widely available vaccine and second global outbreak](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14412.md)
* [Rapid spread of infectious diseases due to limited transportation networks and early shutdowns](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19704.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Lawal_covid-19_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_511.md)
* [Shorfuzzaman_towards_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_569.md)
* [Sovacool_contextualizing_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_560.md)
* [Willems_how_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_676.md)

